Breaking 19:45 Nasa tests autonomous navigation technology for spacecraft 19:25 U.S. Treasury holdings diverge among major economies and Arab investors 17:47 OpenAI strengthens ChatGPT safety measures for teenage users 17:30 Elon Musk’s fortune nears $900 billion as SpaceX valuation surges 17:10 Morocco to benefit from F-16 engine overhaul program under $470 million international contract 15:47 Cybersecurity: Morocco Ranks 43rd Worldwide in the 2026 Ranking 15:25 Anthropic Enhances Text Identification for Claude with Invisible Watermarking 15:23 Canada: New 50% U.S. Tariffs Threaten $20 Billion in Imports 14:45 U.S. Court Blocks Trump Administration Plan To Move FBI Headquarters 13:45 53% of Americans Say Their Finances Have Worsened Since Trump Returned to the White House 12:47 Melania Trump records historically low approval rating among first ladies 12:42 Syria: Washington Condemns Israeli Strikes and Warns of Further Escalation 12:33 OpenAI defends leadership stability amid executive departures 12:16 Anthropic’s revenue surges as the global artificial intelligence race intensifies 10:32 Trump says contacts with Hamas are advancing as disarmament talks continue 10:00 Trump signals major reduction in US-South Korea drills as North Korea dialogue returns to focus 08:46 US-Iran Crisis: Why Oil Prices Are Climbing Above $90 08:10 Philippines: Manila reassures on military alliance with the United States despite redeployment to the Middle East 07:55 United States: Trump Administration Pauses Major Border Security Project in Texas 07:50 Guterres urges Washington and Tehran to quickly resume negotiations 07:48 US Claims to Have Blocked 64 Ships from Iranian Ports Since July

Health



Germany approves first cannabis-based chronic pain medication Exilby

A biopharmaceutical company has secured regulatory approval in Germany and Austria for a cannabis-derived oral treatment targeting chronic lower back pain with neuropathic features. The product, Exilby (VER-01), becomes the first cannabis-based medicine explicitly authorized for chronic pain management......

Johnson & Johnson wins lawsuit over talc-related cancer claims

Johnson & Johnson has secured a legal victory in a high-profile lawsuit involving allegations that its talc-based products caused ovarian cancer. A jury in Los Angeles ruled in favor of the healthcare giant, concluding that the company was not negligent in the marketing and sale of its cosmetic talc......

U.S. treatment centers prepared for Ebola as global outbreak concerns persist

Hospitals across the United States that specialize in high-risk infectious diseases are reportedly prepared to treat Ebola patients if necessary, even as concerns remain over ongoing outbreak responses in Africa and planning efforts in other regions such as Kenya. Officials from a federally funded network......

United States to Re-engage with Gavi vaccine alliance amid Ebola outbreak, Rubio says

The United States has announced that it will resume its cooperation with the global vaccine partnership Gavi, the Vaccine Alliance, following growing concerns over an Ebola outbreak affecting several African countries. U.S. Secretary of State Marco Rubio stated during a Senate Foreign Relations Committee......

Kenya defends U.S.-backed Ebola quarantine facility amid public concerns

Kenyan authorities have defended plans to establish a U.S.-supported Ebola quarantine facility at a military air base, arguing that the project forms part of broader efforts to strengthen public health preparedness and emergency response capabilities. The initiative has generated considerable public......

J&J injectable cancer drug eliminates tumors in head and neck cancer patients

Results from an international clinical trial presented at the annual meeting of the American Society of Clinical Oncology show that a subcutaneous cancer injection can eradicate or reduce tumors in patients who have exhausted standard treatment options. The phase Ib/II OrigAMI-4 trial evaluated subcutaneous......

Akeso lung cancer drug cuts death risk by 34 percent in major clinical trial

A experimental lung cancer drug developed by Chinese biopharmaceutical company Akeso reduced the risk of death by 34 percent compared to an established immunotherapy, according to results presented Saturday at the annual meeting of the American Society of Clinical Oncology. The findings mark a significant......

New study shows promising results for J&J prostate cancer treatment

A new clinical study has revealed encouraging results for patients with high-risk prostate cancer, showing that a treatment regimen developed by Johnson & Johnson may significantly improve outcomes and reduce the risk of disease progression. The findings were presented at the annual meeting of the......

CVS restores coverage for Lilly’s obesity drug Zepbound

The American healthcare company CVS Health has announced that it will reinstate insurance coverage for Eli Lilly’s obesity treatment Zepbound, marking a significant shift in its pharmacy benefit policies. The decision was made by CVS Caremark, the company’s pharmacy benefit management division,......

Measles outbreak in Bangladesh surpasses 500 deaths as hospitals struggle

Bangladesh is facing its most severe measles outbreak in decades, with more than 500 children reported dead and health facilities across the country overwhelmed by a rapidly rising number of suspected infections. The crisis has spread across all 64 districts, placing sustained pressure on hospitals already......

DR Congo Ebola outbreak surpasses 1,000 cases amid rapid spread fears

The Ebola outbreak in the Democratic Republic of the Congo has surpassed 1,000 suspected and confirmed cases, intensifying concerns over a fast-moving health emergency centered in the country’s eastern provinces. World Health Organization Director-General Tedros Adhanom Ghebreyesus confirmed the......

United States expands Ebola screening to Atlanta Airport amid rising concerns

The United States has expanded its enhanced Ebola screening program to include Hartsfield-Jackson Atlanta International Airport, according to the Centers for Disease Control and Prevention, as authorities respond to ongoing concerns over outbreaks in Africa. The decision means that travelers arriving......

Countries expand airport Ebola screening after WHO emergency declaration

Airports across Asia and other regions have tightened health screening measures following a global emergency declaration linked to Ebola outbreaks in Central Africa. The alert, issued on 17 May by the World Health Organization, concerns rising infections in the Democratic Republic of the Congo and Uganda......

  • Fajr
  • Sunrise
  • Dhuhr
  • Asr
  • Maghrib
  • Isha

This website, walaw.press, uses cookies to provide you with a good browsing experience and to continuously improve our services. By continuing to browse this site, you agree to the use of these cookies.